NCT05481021 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Agha A, Basu A, Hanif W
Burnout in diabetes and endocrinology specialist registrars across England, Scotland and Wales in the pre-COVID era. Prim Care Diabetes. 2022 Aug;16(4):515-518. doi: 10.1016/j.pcd.2022.05.005. Epub 2022 Jun 3.
Agha A, Mordy A, Anwar E, Saleh N, Rashid I, Saeed M
Burnout among middle-grade doctors of tertiary care hospital in Saudi Arabia. Work. 2015;51(4):839-47. doi: 10.3233/WOR-141898.
Gundersen L
Physician burnout. Ann Intern Med. 2001 Jul 17;135(2):145-8. doi: 10.7326/0003-4819-135-2-200107170-00023. No abstract available.

Assessing the Frequency of Burnout Syndrome Among Diabetes Specialist Trainee Registrars in United Kingdom and Identifying Any Associated Factors

Clinical trial NCT05481021 - References